Literature DB >> 10951198

Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase.

I Klemencic1, A K Carmona, M H Cezari, M A Juliano, L Juliano, G Guncar, D Turk, I Krizaj, V Turk, B Turk.   

Abstract

Cathepsin X, purified to homogeneity from human liver, is a single chain glycoprotein with a molecular mass of approximately 33 kDa and pI 5.1-5.3. Cathepsin X was inhibited by stefin A, cystatin C and chicken cystatin (Ki = 1.7-15.0 nM), but poorly or not at all by stefin B (Ki > 250 nM) and L-kininogen, respectively. The enzyme was also inhibited by two specific synthetic cathepsin B inhibitors, CA-074 and GFG-semicarbazone. Cathepsin X was similar to cathepsin B and found to be a carboxypeptidase with preference for a positively charged Arg in P1 position. Contrary to the preference of cathepsin B, cathepsin X normally acts as a carboxymonopeptidase. However, the preference for Arg in the P1 position is so strong that cathepsin X cleaves substrates with Arg in antepenultimate position, acting also as a carboxydipeptidase. A large hydrophobic residue such as Trp is preferred in the P1' position, although the enzyme cleaved all P1' residues investigated (Trp, Phe, Ala, Arg, Pro). Cathepsin X also cleaved substrates with amide-blocked C-terminal carboxyl group with rates similar to those of the unblocked substrates. In contrast, no endopeptidase activity of cathepsin X could be detected on a series of o-aminobenzoic acid-peptidyl-N-[2,-dinitrophenyl]ethylenediamine substrates. Furthermore, the standard cysteine protease methylcoumarine amide substrates (kcat/Km approximately 5.0 x 103 M-1.s-1) were degraded approximately 25-fold less efficiently than the carboxypeptidase substrates (kcat/Km approximately 120.0 x 103 M-1.s-1).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951198     DOI: 10.1046/j.1432-1327.2000.01592.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  22 in total

Review 1.  Lysosomal cysteine proteases: facts and opportunities.

Authors:  V Turk; B Turk; D Turk
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases.

Authors:  Aurelio Resende Lima; Luiz Juliano; Maria Aparecida Juliano
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

3.  Carbohydrate- and conformation-dependent cargo capture for ER-exit.

Authors:  Christian Appenzeller-Herzog; Beat Nyfeler; Peter Burkhard; Inigo Santamaria; Carlos Lopez-Otin; Hans-Peter Hauri
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

Review 4.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

5.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

6.  Evaluation of the catalytic specificity, biochemical properties, and milk clotting abilities of an aspartic peptidase from Rhizomucor miehei.

Authors:  Ronivaldo Rodrigues da Silva; Tatiane Beltramini Souto; Tássio Brito de Oliveira; Lilian Caroline Gonçalves de Oliveira; Daniel Karcher; Maria Aparecida Juliano; Luiz Juliano; Arthur H C de Oliveira; André Rodrigues; Jose C Rosa; Hamilton Cabral
Journal:  J Ind Microbiol Biotechnol       Date:  2016-05-10       Impact factor: 3.346

7.  Lysosomal protease expression in mature enamel.

Authors:  Coralee E Tye; Rachel L Lorenz; John D Bartlett
Journal:  Cells Tissues Organs       Date:  2008-08-15       Impact factor: 2.481

8.  CA-074Me protection against anthrax lethal toxin.

Authors:  Zachary L Newman; Stephen H Leppla; Mahtab Moayeri
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

Review 9.  The role of cathepsin X in cell signaling.

Authors:  Janko Kos; Zala Jevnikar; Natasa Obermajer
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405

10.  Cysteine protease cathepsin X modulates immune response via activation of beta2 integrins.

Authors:  Natasa Obermajer; Urska Repnik; Zala Jevnikar; Boris Turk; Marko Kreft; Janko Kos
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.